MARGUGLIO DAVID J. (Sr VP of Business Development) sold 16.4% of their position (50.76K shares) of DMK PHARMACEUTICALS CORP on the open market
Open‑market sale worth $39.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2021ACC: 0001387131-21-011776
DirectorOfficer· Sr VP of Business Development
Since Jan 2019
-50.76K
Net shares
Net seller
$39.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
50.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−50.76K
Price / share
$0.79
Trade value
$39.84K
% of position
16.4%
12/1/2021
309.52K→258.76K
Total
Net shares
−50.76K
Net value
-$39.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2021 | S · Sale | −50.76K | $0.79 | $39.84K | 16.4% | 309.52K | 258.76K |
| Total | −50.76K | -$39.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.88K
Total
5.88K indirect5.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.88K | Indirect |
| Total | 5.88K | 5.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported